Patent Litigation Settlement and License between Merck Millipore and W. L. Gore & Associates, Inc.

News May 02, 2013

Gore has agreed to take a limited royalty-bearing license under U.S. Patent Nos. 7,293,744 and 7,927,316 and U.S. Reissue No. RE41,169, and their counterparts internationally in connection with its STA-PURE Fluid Sampling Systems and assemblies, Crimp and Cut tools, and STA-PURE Single Use Valve Systems and assemblies.

"Our customers rely on us to be technology leaders for innovation in biopharmaceutical production and, as such, Merck Millipore will continue to vigorously defend its intellectual property," said Andrew Bulpin, Executive Vice President for Merck Millipore Process Solutions.

Scientists Develop Platform to Kill Cancer Cells

News

For the first time ever, scientists have shown that a hybrid nanomaterial based on magnetite-gold particles can serve as a universal platform to both detect cancer cells anywhere in the body and to complete targeted deliveries of drugs to these cells.

Molecular Switch May Serve as New Target for Cancer and Diabetes Therapies

News

If certain signaling cascades are misregulated, diseases like cancer, obesity and diabetes may occur. A recently discovered mechanism has a crucial influence on such signaling cascades and may be an important key for the future development of therapies against these diseases.